Oncofertility

Oncofertility is an area of reproductive medicine that focuses on fertility preservation for individuals undergoing cancer treatment or other medical treatments that may affect future reproductive potential.

Cancer treatments such as chemotherapy, radiation therapy, surgery, and certain combined treatment protocols may affect ovarian, testicular, or hormonal function depending on the type of treatment, dose, age, diagnosis, and individual clinical condition.

Fertility preservation counseling is preferably considered before starting cancer treatment wherever clinically feasible. The decision depends on multiple factors including the type of cancer, urgency of treatment, age, reproductive status, medical condition, and time available before oncology treatment begins.

Fertility preservation options may include sperm freezing, oocyte freezing, embryo freezing, ovarian tissue cryopreservation, testicular sperm retrieval, reproductive organ shielding, ovarian transposition, or other approaches depending on the clinical situation and treating specialists’ recommendations.

In women, fertility preservation may involve ovarian stimulation followed by oocyte or embryo cryopreservation in selected cases. In certain urgent or specific clinical situations, alternative approaches may be discussed based on oncology and reproductive medicine assessment.

In men, sperm cryopreservation may be considered before cancer treatment where clinically appropriate. In selected cases where sperm is not present in the semen sample or collection is not possible, surgical sperm retrieval may be considered depending on clinical evaluation.

Oncofertility care requires coordination between oncology specialists, reproductive medicine specialists, embryology teams, and the patient or family. Counseling should include discussion of clinical suitability, treatment timelines, possible risks, limitations, documentation requirements, and applicable regulatory protocols.

Fertility preservation procedures and future reproductive outcomes vary depending on medical, biological, oncological, and reproductive factors. Oncofertility at Krishna IVF forms part of broader clinical embryology, fertility preservation, and individualized reproductive medicine workflows.

Research activities related to cryopreservation and embryology workflows from Krishna IVF have contributed to published scientific literature in reproductive medicine.